DAFNA CAPITAL MANAGEMENT
DAFNA Capital Management, LLC, a Los Angeles based SEC registered investment advisor, specializes in managing long/short portfolios of predominantly publicly traded biotechnology and medical device companies. Founded in 1999, for over 17 years we have merged unparalleled expertise, intellectual curiosity, and investment rigor to fund the future of medicine and prudently manage the wealth entrusted with us by our investors
DAFNA CAPITAL MANAGEMENT
Founded:
1999-01-01
Status:
Active
Email Addresses:
[email protected]
Total Funding:
36.8 M ILS
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default LetsEncrypt Apple Mobile Web Clips Icon Content Delivery Network Microsoft Exchange Online Office 365 Mail Microsoft Azure DNS
Similar Organizations
AUM LifeTech
AUM LifeTech is a Philadelphia based biotechnology company with a revolutionary nucleic acids platform.
DV Capital Management
DV Capital Management is an investment advisory firm that specializes in asset management and portfolio management services.
RA Capital Management
RA Capital Management is an investment advisor specializing in the life-sciences and drug development sectors.
Current Employees Featured
Founder
Investors List
Cybele Holdings
Cybele Holdings investment in Venture Round - Dafna Capital Management
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2021-06-16 | KAHR medical | Dafna Capital Management investment in Venture Round - KAHR medical | 46.5 M USD |
| 2021-02-08 | Gemini Therapeutics | Dafna Capital Management investment in Post-IPO Equity - Gemini Therapeutics | 95 M USD |
| 2017-10-10 | ObsEva | Dafna Capital Management investment in Post-IPO Equity - ObsEva | 60 M USD |
| 2016-07-18 | Ardelyx | Dafna Capital Management investment in Post-IPO Equity - Ardelyx | 110 M USD |
| 2016-06-10 | Corbus Pharmaceuticals | Dafna Capital Management investment in Post-IPO Equity - Corbus Pharmaceuticals | 14.8 M USD |
| 2016-06-03 | arGEN-X | Dafna Capital Management investment in Post-IPO Equity - arGEN-X | 30 M EUR |
| 2015-03-24 | Minerva Neuroscience | Dafna Capital Management investment in Post-IPO Equity - Minerva Neuroscience | 31 M USD |
| 2010-09-24 | Cascadian Therapeutics | Dafna Capital Management investment in Post-IPO Equity - Cascadian Therapeutics | 14.9 M USD |
| 2010-08-09 | Raptor Pharmaceuticals | Dafna Capital Management investment in Post-IPO Equity - Raptor Pharmaceuticals | 15 M USD |
| 2010-07-02 | Soligenix | Dafna Capital Management investment in Venture Round - Soligenix | 5.9 M USD |